Experimental depression treatment is nearly 80% effective in controlled study (med.stanford.edu)

Article summary

Researchers at Stanford University have developed an experimental depression treatment called Stanford accelerated intelligent neuromodulation therapy (SAINT), which uses high doses of magnetic brain stimulation to target individual neurocircuitry. In a controlled study, 79% of participants with severe depression experienced remission within days, with the effects lasting for months. The treatment was found to be effective and safe, with only temporary fatigue and headaches as side effects. The study's results suggest that SAINT could be a game-changer in the treatment of depression.

Main themes

• depression treatment
• magnetic brain stimulation
• personalized medicine
• neuroscience
• mental health
• medical ethics

What commenters say

• The treatment's high success rate and rapid effects make it a promising option for patients with treatment-resistant depression.
• The use of magnetic stimulation raises concerns about the potential for adverse effects or unintended consequences, such as inducing depression or other conditions.
• The personalized nature of the treatment, which uses fMRI data to target individual brain areas, may be a key factor in its effectiveness.
• Some commenters are skeptical about the treatment's mechanism and potential for long-term benefits, citing the need for further research and caution.
• The comparison to other treatments, such as electroconvulsive therapy or medication, highlights the need for careful consideration of the risks and benefits of each approach.
• The potential for refinement and improvement of the treatment over time, as with other medical therapies, is seen as a positive aspect.
• The discussion around the treatment's potential to induce happiness or other emotional states raises questions about the complexity of human emotions and the ethics of manipulating them.